Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study-Reference-Cited by-同舟云学术

Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study

Published:2021-05-29 Issue: Volume: Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet Cardio Intervent

Author:

Karmpaliotis Dimitrios¹,Stoler Robert²,Walsh Simon³,El‐Jack Seif⁴,Potluri Srinivasa⁵,Moses Jeffrey¹,Oldroyd Keith⁶,Banning Adrian⁷,Webster Mark⁸^ORCID,Zaman Azfar⁹,Wu Willis¹⁰,Ahmed Mudassar¹¹,Underwood Paul¹²,Allocco Dominic¹²

Affiliation:

1. Interventional Cardiology, New York Presbyterian Hospital Columbia University Medical Center New York New York USA

2. Baylor Scott & White Heart and Vascular Hospital Dallas Texas USA

3. Royal Victoria Hospital Belfast UK

4. North Shore Hospital Auckland New Zealand

5. Baylor Scott and White The Heart Hospital Plano Plano Texas USA

6. Golden Jubilee National Hospital Glasgow UK

7. John Radcliffe Hospital Oxford UK

8. Auckland City Hospital Auckland New Zealand

9. Freeman Hospital and Newcastle University Newcastle UK

10. Rex Hospital Raleigh North Carolina USA

11. M Health Fairview St Joseph's Hospital St. Paul Minnesota USA